Journal of Pharmacology and Experimental Therapeutics
-
Publication Venue For
-
Nicotinamide Phosphoribosyltransferase Deficiency Potentiates the Antiproliferative Activity of Methotrexate through Enhanced Depletion of Intracellular ATP..
365:96-106.
2018
-
Interaction of CRF and kappa opioid systems on GABAergic neurotransmission in the mouse central amygdala..
355:206-211.
2015
-
M1 polarization bias and subsequent nonalcoholic steatohepatitis progression is attenuated by nitric oxide donor DETA NONOate via inhibition of CYP2E1-induced oxidative stress in obese mice..
352:77-89.
2015
-
TD-19, an erlotinib derivative, induces epidermal growth factor receptor wild-type nonsmall-cell lung cancer apoptosis through CIP2A-mediated pathway..
351:352-358.
2014
-
Treatment with the 3-ketoacyl-CoA thiolase inhibitor trimetazidine does not exacerbate whole-body insulin resistance in obese mice..
349:487-496.
2014
-
N-aryl piperazine metabotropic glutamate receptor 5 positive allosteric modulators possess efficacy in preclinical models of NMDA hypofunction and cognitive enhancement..
347:438-457.
2013
-
Low-dose methotrexate results in the selective accumulation of aminoimidazole carboxamide ribotide in an erythroblastoid cell line..
347:154-163.
2013
-
κ-Opioid receptors in the central amygdala regulate ethanol actions at presynaptic GABAergic sites..
346:130-137.
2013
-
The role of voltage-gated potassium channels Kv2.1 and Kv2.2 in the regulation of insulin and somatostatin release from pancreatic islets..
344:407-416.
2013
-
Chronic sazetidine-A at behaviorally active doses does not increase nicotinic cholinergic receptors in rodent brain..
343:441-450.
2012
-
P-glycoprotein is a major determinant of norbuprenorphine brain exposure and antinociception..
343:53-61.
2012
-
Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats..
338:890-896.
2011
-
Neuroprotective efficacy from a lipophilic redox-modulating Mn(III) N-Hexylpyridylporphyrin, MnTnHex-2-PyP: rodent models of ischemic stroke and subarachnoid hemorrhage..
338:906-916.
2011
-
Role of cannabinoid receptor type 1 desensitization in greater tetrahydrocannabinol impairment of memory in adolescent rats..
335:294-301.
2010
-
B-cell depletion in vitro and in vivo with an afucosylated anti-CD19 antibody..
335:213-222.
2010
-
Differential sensitivity of hippocampal interneurons to ethanol in adolescent and adult rats..
335:51-60.
2010
-
Dopamine uptake inhibitors but not dopamine releasers induce greater increases in motor behavior and extracellular dopamine in adolescent rats than in adult male rats..
335:124-132.
2010
-
An apolipoprotein E-mimetic stimulates axonal regeneration and remyelination after peripheral nerve injury..
334:106-115.
2010
-
Pharmacological targeting of the mitochondrial phosphatase PTPMT1..
333:584-592.
2010
-
Sazetidine-A, a selective alpha4beta2 nicotinic receptor desensitizing agent and partial agonist, reduces nicotine self-administration in rats..
332:933-939.
2010
-
CYP2C9*1B promoter polymorphisms, in linkage with CYP2C19*2, affect phenytoin autoinduction of clearance and maintenance dose..
332:599-611.
2010
-
The metabotropic glutamate receptor subtype 5 antagonist fenobam is analgesic and has improved in vivo selectivity compared with the prototypical antagonist 2-methyl-6-(phenylethynyl)-pyridine..
330:834-843.
2009
-
A positive modulator of K Ca 2 and K Ca 3 channels, 4,5-dichloro-1,3-diethyl-1,3-dihydro-benzoimidazol-2-one (NS4591), inhibits bladder afferent firing in vitro and bladder overactivity in vivo..
328:28-39.
2009
-
Mu-opioid receptors selectively regulate basal inhibitory transmission in the central amygdala: lack of ethanol interactions..
328:284-293.
2009
-
Inhibition of native and recombinant nicotinic acetylcholine receptors by the myristoylated alanine-rich C kinase substrate peptide..
327:884-890.
2008
-
In vivo profile of ICA-27243 [N-(6-chloro-pyridin-3-yl)-3,4-difluoro-benzamide], a potent and selective KCNQ2/Q3 (Kv7.2/Kv7.3) activator in rodent anticonvulsant models..
326:818-828.
2008